The Centers for Medicare & Medicaid Services today updated its Medicare and Medicaid drug spending  with 2017 data. The dashboards show trends in average spending per dosage unit for prescription drugs paid under Medicare Parts B and D and Medicaid, drugs with limited to no competition, and the list price of different medications for a given condition. 鈥淭he dashboards pinpoint the sources of rising prescription drug prices to help guide our continued work to address this problem,鈥 CMS Administrator Seema Verma. 鈥淔rom 2013-2017, prescription drug spending grew at an average annual rate of 10.6 percent in Medicare Part D, 10.0 percent in Part B, and 14.8 percent in Medicaid 鈥 this is one of our fastest areas of growth.鈥 In 2017, total gross spending on prescription drugs was $154.9 billion in Medicare Part D, $30.4 billion in Part B, and $67.6 billion in Medicaid.   
 

Related News Articles

Headline
The Trump administration today announced steps drug manufacturers must take to lower prescription drug prices in the U.S. to "most favored nation" pricing, the鈥
Headline
The Department of Health and Human Services today issued a notice announcing a 340B Rebate Model Pilot Program as a voluntary mechanism for qualifying drug鈥
Headline
The Department of Health and Human Services May 20 announced it has identified specific pricing targets for pharmaceutical manufacturers to meet to satisfy鈥
Headline
The Centers for Medicare & Medicaid Services May 12 released draft guidance for the third round of negotiations for the Medicare Drug Price Negotiation鈥
Headline
The White House May 12 released an executive order to reduce prescription drug costs by allowing consumers to make direct purchases from drug manufacturers at鈥
Headline
The White House April 15 released an executive order directing federal agencies to undertake a broad range of tasks aimed at reducing the costs of prescription鈥